focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMyhlth Chck Regulatory News (MHC)

Share Price Information for Myhlth Chck (MHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.50
Bid: 9.00
Ask: 10.00
Change: 0.50 (5.56%)
Spread: 1.00 (11.111%)
Open: 9.00
High: 9.50
Low: 9.00
Prev. Close: 9.00
MHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

4 Jun 2021 07:01

RNS Number : 7823A
MyHealthChecked PLC
04 June 2021
 

MyHealthChecked Plc

("MyHealthChecked" or the "Company")

 

Board Changes

 

Appointment of full-time Chief Financial and Operations Officer to strengthen operational leadership

 

MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, announces the appointment of Gareth Davies as Chief Financial and Operations Officer, a full-time role that will involve day-to-day operational oversight of the business during a period of substantial growth. Gareth succeeds Maddy Kennedy, who joined the Company in October 2019 with a remit to drive the cost efficiencies successfully delivered in 2020. Maddy is leaving her part-time CFO post to pursue her CFO/NED portfolio following the Company relocation to Cardiff, and to facilitate the transition to the full-time operational role to meet expected growth demands. Gareth will take up the position of CFO/COO and joins the Board on 4 June 2021. Maddy Kennedy will step down from the Board at the same time, but will continue to provide Company Secretarial support services to the Company during a transition period.

 

Gareth, a Chartered Accountant, is a commercially astute and driven business leader with extensive experience gained in finance and operations leadership within high growth medical device businesses, most recently with Welcony Inc, a leader in neurotechnology, as Group Chief Finance & Operations Officer since 2017.

 

During his time at Welcony, Gareth was part of a leadership team that led the business through a period of significant revenue and profitability growth. Prior to Welcony Inc, Gareth was Finance Director & General Manager at Flexicare (Group) Limited for 11 years from 2006 to 2017.

 

Gareth has extensive experience within high growth medical device businesses, covering operational and manufacturing processes, organic business scale up and cross border M&A activity.

 

Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, commented:

"Gareth is joining us at a dynamic transitionary period for MyHealthChecked Plc, and he brings healthcare sector expertise along with deep, proven experience across operations and finance. This includes M&A, and process driven infrastructural developments, both essential in underpinning our medium to long term growth. We welcome Gareth to our Board at this exciting time, and wish him every success as he transitions the role significantly in line with our business plan. In doing so, on behalf of the Board I'd like to thank Maddy for her loyalty to the Group and delivery of key financial projects over the past 20 months, with our full support and good wishes for her future endeavours."

 

The following additional information is provided in accordance with paragraph (g) of Schedule Two to the AIM Rules for Companies:

 

David Gareth Lloyd Davies (44) is currently or has been a director of the following companies within the previous five years:

 

Current directorships/partnerships

Past directorships/partnerships

None

The Magstim Company Limited

Flexicare (Group) Limited

 

Flexicare Medical Limited

Wymedical Ltd

 

Mr Davies does not have any beneficial interest in the ordinary shares of the Company.

 

Save as set out above, no further information is required to be disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

 

MyHealthChecked PLC

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR

 

 

 

 

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

 

 

 

Oberon Capital Ltd (Broker)

Tel: +44 (0)203 179 5344

Mike Seabrook

mikeseabrook@oberoninvestments.com

 

 

Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44 (0) 7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests. MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online and would be viable for over-the-counter purchase. 

 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market, with a focus on accessibility at the right price, led by UK-based experts.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKNBKPBKDNAK
Date   Source Headline
11th Apr 20227:00 amRNSDirectorate Changes
25th Mar 20227:00 amRNSIssue of Equity
16th Mar 20222:05 pmRNSSecond Price Monitoring Extn
16th Mar 20222:00 pmRNSPrice Monitoring Extension
7th Mar 20222:06 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
3rd Mar 20221:05 pmRNSDirectorate Change
28th Feb 202211:05 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension
2nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
2nd Feb 20224:36 pmRNSPrice Monitoring Extension
24th Jan 20227:00 amRNSTrading Update
5th Jan 20227:00 amRNSPartnership with Lloyds for COVID Antigen testing
13th Dec 20214:40 pmRNSSecond Price Monitoring Extn
13th Dec 20214:35 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSTrading update
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20214:41 pmRNSSecond Price Monitoring Extn
1st Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 202111:06 amRNSSecond Price Monitoring Extn
1st Dec 202111:00 amRNSPrice Monitoring Extension
29th Nov 202111:06 amRNSSecond Price Monitoring Extn
29th Nov 202111:01 amRNSPrice Monitoring Extension
26th Nov 202111:05 amRNSSecond Price Monitoring Extn
26th Nov 202111:00 amRNSPrice Monitoring Extension
25th Nov 202111:06 amRNSSecond Price Monitoring Extn
25th Nov 202111:00 amRNSPrice Monitoring Extension
24th Nov 20219:05 amRNSSecond Price Monitoring Extn
24th Nov 20219:00 amRNSPrice Monitoring Extension
24th Nov 20217:00 amRNSLaunch of COVID-19 rapid antigen test service
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20217:00 amRNSBoard Change
29th Sep 20219:05 amRNSSecond Price Monitoring Extn
29th Sep 20219:00 amRNSPrice Monitoring Extension
29th Sep 20217:00 amRNSHalf-year Report
20th Sep 20212:01 pmRNSPrice Monitoring Extension
20th Sep 20217:00 amRNSStatement re. COVID-19 testing
17th Sep 20215:50 pmRNSStatement re. COVID-19 testing
13th Sep 20219:07 amRNSSecond Price Monitoring Extn
13th Sep 20219:03 amRNSPrice Monitoring Extension
7th Sep 20217:00 amRNSNotice of Results & Q3 Trading Update
1st Sep 20217:00 amRNSMedical laboratory accreditation for COVID testing
26th Aug 202111:05 amRNSSecond Price Monitoring Extn
26th Aug 202111:01 amRNSPrice Monitoring Extension
24th Aug 20217:00 amRNSStatement re. DHSC press release
30th Jul 20217:00 amRNSIssue of equity/PDMR Dealing
7th Jul 202111:06 amRNSSecond Price Monitoring Extn
7th Jul 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.